Laboratory Automation Market to Reach USD 6.3 Billion by 2035, Growing at 9.7% CAGR Analysis by Future Market Insight

Future Market Insights (FMI), a premier market research and consulting firm, today announced the publication of its latest in-depth report titled "Lab Automation Market Size, Trends & Forecast 2025-2035." This comprehensive analysis forecasts robust growth in the global lab automation sector, highlighting its evolution amid technological advancements, rising demand for efficiency in research and diagnostics, and the integration of cutting-edge AI and robotics. As laboratories worldwide grapple with increasing workloads and the need for precision, the report underscores how automation is transforming workflows, reducing human error, and accelerating scientific breakthroughs.

The market for laboratory automation is expected to grow significantly from 2025 to 2035, as it will be worth about USD 2.5 billion in 2025, increase to over USD 6.3 billion at a 9.7% annual growth rate by 2035. High-throughput screening, microplate readers, and liquid-handling robots are all being favoured in the marketplace with the drive toward automated, miniaturized labs.This growth trajectory reflects the industry's shift toward high-throughput screening, miniaturized labs, and personalized medicine, positioning lab automation as a cornerstone for innovation in pharmaceuticals, biotechnology, and clinical diagnostics. With insights drawn from extensive data analysis, stakeholder interviews, and global trends, the report equips businesses, investors, and policymakers with actionable intelligence to navigate this dynamic market.

Laboratory Automation Market Insights: Trends, Drivers, Challenges, Opportunities, and Competitive Landscape:

The FMI report delves into key market dynamics, painting a vivid picture of the lab automation landscape. Central to the growth are trends such as the adoption of high-throughput screening tools, microplate readers, and liquid-handling robots, which are favored in automated and miniaturized lab environments. The integration of laboratory information management systems (LIMS) and laboratory execution systems (LES) is enhancing operational efficiency and ensuring compliance with stringent quality standards.

Growth drivers are multifaceted. The surge in personalized medicine and the escalating prevalence of chronic diseases are propelling demand for faster biomarker identification and reduced drug-to-market timelines. Automation platforms are enabling quicker patient outcomes by streamlining processes in biomedical research and drug development. Additionally, the reconstruction of research labs to elevate performance is opening avenues for providers to innovate in continuous operation management solutions.

Opportunities abound, particularly with advances in AI and robotics. The report highlights the potential for AI-driven analytics to minimize errors, boost productivity, and enable remote operations through cloud-based platforms. High-throughput screening technologies are fostering reproducibility in experimental results, while sustainability initiatives—such as energy-efficient equipment and recyclable materials—are aligning with global environmental goals. The competitive landscape is vibrant, with established players dominating through innovation in robotic workflows and AI integration. Market share analysis shows Thermo Fisher Scientific, Inc. leading with 15-20%, followed by Beckman Coulter (Danaher Corporation) at 12-16%, Siemens Healthineers AG at 10-14%, PerkinElmer, Inc. at 8-12%, and Agilent Technologies, Inc. at 5-9%. Other companies, including Tecan Group Ltd., Hamilton Company, BD (Becton, Dickinson and Company), Hudson Robotics, Inc., and Eppendorf AG, collectively hold 40-50%, contributing through specialized offerings like precision pipetting and high-throughput screening.

Laboratory Automation Market News: A Detailed Industry Update:

The lab automation sector has seen accelerated momentum in 2024 and early 2025, with AI and automation emerging as dominant trends. According to recent industry reports, AI integration is revolutionizing total lab automation (TLA), enhancing diagnostic accuracy, predictive analytics, and workflow optimization. For instance, in September 2025, Eppendorf launched the VisioNize box, a innovative IoT-enabled device for remote lab monitoring, underscoring the shift toward connected, smart labs.

Industry experts, as highlighted in a November 2024 CLP Magazine survey, predict automation and AI as top clinical laboratory trends for 2025, building on 2024's advancements in robotic sample handling and cloud computing. Market valuations vary but confirm growth: one analysis pegs the market at USD 5.97 billion in 2024, rising to USD 6.36 billion in 2025, with projections to USD 9.01 billion by 2030 at 7.2% CAGR. Another estimates USD 8.27 billion in 2024, emphasizing AI's role in lab efficiency.

Regulatory landscapes are evolving, with enhanced global frameworks for AI-integrated systems focusing on reliability and data integrity. Supply chain dynamics have stabilized post-2024 disruptions, aided by predictive AI inventory management. Shifts from 2020-2024 included increased cloud adoption for data sharing and high-throughput screening amid rising research demands, setting the stage for 2025-2035 projections of fully autonomous labs, blockchain-secured data, and sustainable practices.

Laboratory Automation Market Applications: Benefiting Diverse Sectors:

The FMI report's findings offer tangible benefits across industries. In pharmaceuticals and biotechnology, automation optimizes drug discovery by expediting high-throughput screening and lead selection, reducing timelines and costs—critical for companies like Thermo Fisher and Agilent facing competitive pressures. Hospitals and diagnostic centers gain from faster turnaround times in clinical testing, improving patient outcomes in pathology and microbiology amid rising chronic disease burdens.

For research institutes and educational institutions, the insights enable adoption of AI-driven workflows for genomics and proteomics, fostering reproducible results in collaborative studies. Contract Research Organizations (CROs) can leverage modular systems to scale operations, enhancing efficiency in outsourced R&D. Overall, businesses can use the report to strategize investments, mitigate integration challenges, and capitalize on AI opportunities, ultimately driving innovation, compliance, and profitability.

Laboratory Automation Market Key Players:

The report profiles leading companies shaping the market:

• Thermo Fisher Scientific, Inc.: Pioneers in robotic liquid handling and AI-powered platforms.
• Beckman Coulter (Danaher Corporation): Experts in high-speed sample handling and clinical diagnostics.
• Siemens Healthineers AG: Focuses on automated workflows and laboratory information systems.
• PerkinElmer, Inc.: Offers high-throughput screening and bioanalysis for research.
• Agilent Technologies, Inc.: Specializes in precision robotics and chromatography.
• Other notables: Tecan Group Ltd., Hamilton Company, BD, Hudson Robotics, Inc., and Eppendorf AG, advancing pipetting, diagnostics, and cell culture automation.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/checkout/394

Request for Discount: https://www.futuremarketinsights.com/reports/sample/rep-gb-394

Laboratory Automation Recent Developments in the Market:

2024-2025 has been pivotal for lab automation innovations. In September 2025, Eppendorf's VisioNize box launch enhanced remote monitoring, integrating IoT for real-time data access. AI advancements dominated: A GlobeNewswire report from September 2025 noted AI in lab automation growing from USD 5.68 billion in 2024 to USD 6.09 billion in 2025, driven by machine learning for variant calling and predictive diagnostics.

In August 2025, Consegic Business Intelligence highlighted robotic integrations boosting market to USD 6.95 billion in 2025. Earlier, in July 2025, Mordor Intelligence forecasted USD 6.65 billion in 2025, emphasizing self-learning systems. A PMC article in 2025 detailed AI/ML's role in TLA, improving analytics and optimization.

Industry-wide, partnerships like those in South Korea's smart hospitals and Japan's robotics advancements (e.g., Takeda's high-throughput systems) reflect global momentum. These developments align with FMI's projections, signaling a future of autonomous, sustainable labs.

Explore More Related Studies Published by FMI Research:

Hematopoietic Stem Cell Transplantation (HSCT) Market: Valued at USD 8,146.8 million in 2025, projected to reach USD 17,303.4 million by 2035 with a CAGR of 7.8%, driven by advancements in stem cell research and therapies. 

Isocitrate Dehydrogenase Inhibitors Market: Valued at USD 4.0 billion in 2025, projected to reach USD 103.6 billion by 2035 at a CAGR of 33%.

Dyspnea Treatment Market: Estimated at USD 7.22 billion in 2025, expected to hit USD 14.06 billion by 2035 with a CAGR of 6.9%.

Halal Nutraceuticals & Vaccines Market: Forecast to grow from USD 76,996.7 million in 2025 to USD 144,534.3 million by 2035, registering a CAGR of 5.2%.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:    

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube